IRMD
Iradimed·NASDAQ
--
--(--)
--
--(--)
6.50 / 10
Outperform
Technical rating is Outperform with a 6.5 score. MACD Death Cross and Long Upper Shadow provide bullish bias, while Marubozu White is neutral. Recent five‑day signals show two bullish and two neutral cues, indicating a cautiously optimistic trend.
Analysis Checks(3/4)
Long Upper Shadow
Score7.6/10
Win Rate66.67%
Hist. Signals3
Avg Return2.62%
Score7.6/10
Win Rate66.67%
Hist. Signals3
Avg Return2.62%
MACD Golden Cross
Score6.16/10
Win Rate58.33%
Hist. Signals12
Avg Return1.01%
Score6.16/10
Win Rate58.33%
Hist. Signals12
Avg Return1.01%
MACD Death Cross
Score7.99/10
Win Rate69.23%
Hist. Signals13
Avg Return1.35%
Score7.99/10
Win Rate69.23%
Hist. Signals13
Avg Return1.35%
Marubozu White
Score4.25/10
Win Rate52.63%
Hist. Signals19
Avg Return0.98%
Score4.25/10
Win Rate52.63%
Hist. Signals19
Avg Return0.98%
Long Upper Shadow
Score7.6/10
Win Rate66.67%
Hist. Signals3
Avg Return2.62%
Score7.6/10
Win Rate66.67%
Hist. Signals3
Avg Return2.62%
MACD Death Cross
Score7.99/10
Win Rate69.23%
Hist. Signals13
Avg Return1.35%
Score7.99/10
Win Rate69.23%
Hist. Signals13
Avg Return1.35%
MACD Golden Cross
Score6.16/10
Win Rate58.33%
Hist. Signals12
Avg Return1.01%
Score6.16/10
Win Rate58.33%
Hist. Signals12
Avg Return1.01%
Marubozu White
Score4.25/10
Win Rate52.63%
Hist. Signals19
Avg Return0.98%
Score4.25/10
Win Rate52.63%
Hist. Signals19
Avg Return0.98%
What is the current technical signals for IRMD?
- IRMD presents a Outperform setup with a Technical Score of 6.50/10. Key technical indicators highlight an RSI of 38.66 and a MACD of -0.89, with the trend anchored by the 50-Day SMA at 100.38. Traders should monitor key support at 97.39 and resistance at 101.43.
